Using Mycophenolate Mofetil in Steroid-Resistant Nephrotic Syndrome |
PDF
|
Mohammad Reza Ganji |
323-325 |
How Neutrophil Gelatinase-associated Lipocalin Can Be Presented in Plasma and Urine |
PDF
|
Zohreh Rostami, Fatemeh Heidari |
325-327 |
Is a Lower Dose of Cyclosporine Required Among Iranian Kidney Transplant Recipients? |
PDF
|
Mohammad-Hossein Nourbala, Fatemeh Heidari |
327-329 |
Posttransplant Lymphoproliferative Disorders in Kidney Transplant Patients: Central Nervous System Involvement |
PDF
|
Behzad Einollahi |
330-331 |
Actinobaculum Schaalii as a Uropathogen in Immunocompromised Hosts |
PDF
|
Alireza Ghadian |
332-333 |
Mycophenolate Mofetil for Treatment of Idiopathic Nephrotic Syndrome in Children |
PDF
|
Azar Nickavar, Amir Ebrahim Safarzadeh, Kambiz Sotoudeh, Hasan Otukesh, Nakisa Hooman |
346-349 |
A Combination of Vitamin C and Losartan for Cisplatin-induced Nephrotoxicity in Rats |
PDF
|
Farzaneh Ashrafi, Mehdi Nematbakhsh, Tahereh Safari, Ardeshir Talebi, Hamid Nasri, Mehdi Khazaei, Mohammad-Mehdi Baradaran-Mahdavi, Amir Jafapisheh, Behrooz Olia, Omid Pirhaji, Sayyed-Javad Hashemi-Nia, Fatemeh Eshraghi, Zahra Pezeshki, Mojgan Mortazavi |
361-365 |
Multifocal Cranial Plasmablastic Lymphoma as a Rare Manifestation of Posttransplant Lymphoproliferative Disorder |
PDF
|
Aria Jenabi, Ahmad Mooraki, Mosadegh Jabbari, Nasrin Shayanfar, Ahad J Ghods, Mohammad Bagher Ziari, Bahar Bastani |
380-385 |
Cyclosporine trough Level or 2-hour Postdose Level Monitoring Among Kidney Transplant Recipients: Iranian Practice |
PDF
|
Behzad Einollahi, Zohreh Rostami, Mojtaba Teimoori |
389-390 |
Re: Risk Factors Profile and Cardiovascular Events in Solid Organ Transplant Recipients |
PDF
|
Behzad Einollahi, Zohreh Rostami |
390-391 |
Re: Elevated Serum Levels of Vitamin D in Infants With Urolithiasis |
PDF
|
Fatemeh Beiraghdar, Shahin Abbaszadeh |
391-392 |
Re: Maternal Urinary Tract Infection as a Risk Factor For Neonatal Urinary Tract Infection |
PDF
|
Shahin Abbaszadeh, Fatemeh Beiraghdar |
392-393 |